COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
作者信息
Abbasi Jennifer
出版信息
JAMA. 2022 Jan 11;327(2):115. doi: 10.1001/jama.2021.24118.
PMID:35015052
Abstract
摘要
相似文献
1
COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.专注于T细胞反应的新冠疫苗在早期试验中前景可期。
JAMA. 2022 Jan 11;327(2):115. doi: 10.1001/jama.2021.24118.
2
Can immune responses predict which vaccines work best?免疫反应能否预测哪些疫苗效果最佳？
Science. 2021 Jul 9;373(6551):142-143. doi: 10.1126/science.373.6551.142.
3
Covid-19 vaccines: delivering protective immunity.新冠疫苗：提供保护性免疫
BMJ. 2020 Dec 17;371:m4838. doi: 10.1136/bmj.m4838.
4
T cell-oriented strategies for controlling the COVID-19 pandemic.以 T 细胞为导向的策略控制 COVID-19 大流行。
Nat Rev Immunol. 2021 Nov;21(11):687-688. doi: 10.1038/s41577-021-00625-9.
5
T Cell Memory: Understanding COVID-19.T 细胞记忆：了解 COVID-19。
Immunity. 2021 Jan 12;54(1):14-18. doi: 10.1016/j.immuni.2020.12.009. Epub 2020 Dec 19.
6
Coronavirus Disease 2019 Vaccine Development: An Overview.新型冠状病毒肺炎 2019 疫苗研发：概述。
Viral Immunol. 2021 Apr;34(3):134-144. doi: 10.1089/vim.2020.0119. Epub 2020 Sep 23.
7
T cell immunity to COVID-19 vaccines.T 细胞对 COVID-19 疫苗的免疫反应。
Science. 2022 Aug 19;377(6608):821-822. doi: 10.1126/science.add2897. Epub 2022 Aug 18.
8
China's COVID vaccines have been crucial - now immunity is waning.中国的新冠疫苗曾发挥关键作用——如今免疫力正在减弱。
Nature. 2021 Oct;598(7881):398-399. doi: 10.1038/d41586-021-02796-w.
9
How 'killer' T cells could boost COVID immunity in face of new variants.面对新冠病毒新变种，“杀手”T细胞如何增强对新冠的免疫力。
Nature. 2021 Feb;590(7846):374-375. doi: 10.1038/d41586-021-00367-7.
10
IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.白细胞介素 7 在 SARS-CoV-2 感染中的作用及其作为潜在疫苗佐剂的潜力。
Front Immunol. 2021 Sep 17;12:737406. doi: 10.3389/fimmu.2021.737406. eCollection 2021.
引用本文的文献
1
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.鉴定一种对T细胞具有超抗原样刺激特性的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）S2蛋白衍生肽。
Commun Biol. 2025 Jan 6;8(1):14. doi: 10.1038/s42003-024-07350-8.
2
Cellular Immunity-The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination.细胞免疫——从新冠病毒感染中康复及接种疫苗后个体长期保护的关键
Vaccines (Basel). 2022 Mar 14;10(3):442. doi: 10.3390/vaccines10030442.
Zotero 插件